Emerging in the landscape of excess body fat management, retatrutide is a unique strategy. Different from many available medications, retatrutide functions as a double agonist, at once targeting both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) sensors. The dual stimulation promotes various beneficial effects,